Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

09.12.2024

1 Acta Anaesthesiol Scand
1 Adv Sci (Weinh)
1 Anticancer Res
1 Asian J Surg
1 BJU Int
1 Cancer Med
1 Clin Cancer Res
1 Clin Genitourin Cancer
1 Discov Oncol
1 Einstein (Sao Paulo)
1 ESMO Open
1 Eur J Cell Biol
1 Fr J Urol
1 Front Immunol
2 Hinyokika Kiyo
1 Hum Cell
1 Int J Med Sci
3 Int J Urol
1 J Cell Biochem
1 J Clin Invest
1 JCO Precis Oncol
1 Minerva Urol Nephrol
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Nat Biomed Eng
1 Nat Commun
1 Nat Prod Res
1 PeerJ
1 Sci Rep
1 Stem Cells Int
1 Toxicol In Vitro
1 Urol Int
1 Urology
2 World J Urol



    Acta Anaesthesiol Scand

  1. ROMUNDSTAD L, Raeder J
    Does methadone offer any benefits for analgesia over morphine after bladder cancer surgery?
    Acta Anaesthesiol Scand. 2025;69:e14552.
    >> Share


    Adv Sci (Weinh)

  2. DAN W, Fan Y, Wang Y, Hou T, et al
    The Tumor Suppressor TPD52-Governed Endoplasmic Reticulum Stress is Modulated by APC(Cdc20).
    Adv Sci (Weinh). 2024;11:e2405441.
    >> Share


    Anticancer Res

  3. JARADAT JH, Idrissi YA, Saeed A
    HOOK3 Amplification in Bladder Urothelial Carcinoma: Insights from Gene Expression and Survival Analysis.
    Anticancer Res. 2024;44:5175-5185.
    >> Share


    Asian J Surg

  4. WU L, Yang E, Zhang Y, Yin B, et al
    An immune-related lncRNA signature for predicting overall survival and chemotherapy sensitivity in bladder cancer patients.
    Asian J Surg. 2024 Nov 29:S1015-9584(24)02515.
    >> Share


    BJU Int

  5. AKDEMIR E, Stuiver MM, van de Kamp MW, der Hulst JB, et al
    Long-term quality of life in patients with bladder cancer following radical cystectomy.
    BJU Int. 2024 Dec 1. doi: 10.1111/bju.16610.
    >> Share


    Cancer Med

  6. DALL CP, Liu X, Faraj KS, Srivastava A, et al
    Hospital Quality and Racial Differences in Outcomes After Genitourinary Cancer Surgery.
    Cancer Med. 2024;13:e70436.
    >> Share


    Clin Cancer Res

  7. FLECHON A, Morales-Barrera R, Powles T, Alva A, et al
    Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma.
    Clin Cancer Res. 2024;30:5353-5364.
    >> Share


    Clin Genitourin Cancer

  8. MALSHY K, Steidle M, Tabayoyong W, Messing EM, et al
    Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer.
    Clin Genitourin Cancer. 2024;23:102263.
    >> Share


    Discov Oncol

  9. CAO N, Cheng F, Zhou J, Liu N, et al
    Identification and construction of prognostic clusters and risk-prognosis model based on aging-immune related genes in bladder cancer.
    Discov Oncol. 2024;15:742.
    >> Share


    Einstein (Sao Paulo)

  10. DE SOUSA NETO PI, Pinto VBP, Pianco EDS, Gomes ML, et al
    The role of microRNAs in non-invasive diagnosis of bladder cancer: a systematic review.
    Einstein (Sao Paulo). 2024;22:eRW0611.
    >> Share


    ESMO Open

  11. MYERS AA, Fang AM, Moussa MJ, Hwang H, et al
    Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder.
    ESMO Open. 2024;9:103964.
    >> Share


    Eur J Cell Biol

  12. HUANG SY, Yu TS, Lin JH, Liu WH, et al
    Stable laminar shear stress induces G1 cell cycle arrest and autophagy in urothelial carcinoma by a torque sensor-coupled cone-and-plate device.
    Eur J Cell Biol. 2024;103:151451.
    >> Share


    Fr J Urol

  13. PALKOWSKI T, Bibeau F, Thiery-Vuillemin A, Kleinclauss F, et al
    High-Risk Non-Muscle Invasive Bladder Cancer: outcomes of patients who cannot benefit from Standard of Care.
    Fr J Urol. 2024 Dec 3:102838. doi: 10.1016/j.fjurol.2024.102838.
    >> Share


    Front Immunol

  14. ZOU J, Xu B, Luo P, Chen T, et al
    Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?
    Front Immunol. 2024;15:1482765.
    >> Share


    Hinyokika Kiyo

  15. NISHIMURA Y, Oki Y, Nonomura D, Matsuzaki K, et al
    [A Case of Secondary Extramammary Paget's Disease Developed at 11 Years after Cystectomy].
    Hinyokika Kiyo. 2024;70:335-341.
    >> Share

  16. NARA T, Numakura K, Kikuchi A, Sekine Y, et al
    [Four Cases of Bladder Cancer in Young Patients with Severe Motor and Intellectual Disabilities].
    Hinyokika Kiyo. 2024;70:227-231.
    >> Share


    Hum Cell

  17. LIU B, Chen M, Liang Y, Mei Z, et al
    ZC3H13 promotes autophagy in bladder cancer through m6A methylation modification of PJA2 and ubiquitination of KSR1.
    Hum Cell. 2024;38:23.
    >> Share


    Int J Med Sci

  18. YANG X, Zheng H, Huang J, Liu Y, et al
    Co-inhibition of PGF and VEGFA enhances the effectiveness of immunotherapy in bladder cancer.
    Int J Med Sci. 2024;21:2870-2882.
    >> Share


    Int J Urol

  19. PALERMO G, Bizzarri FP, Scarciglia E, Sacco E, et al
    The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score-matched study.
    Int J Urol. 2024;31:1423-1428.
    >> Share

  20. SASAKI Y, Fukuta K, Kadoriku F, Daizumoto K, et al
    Retroperitoneal cutaneous ureterostomy following radical cystectomy: A multicenter comparative study of robotic versus open surgery.
    Int J Urol. 2024;31:1408-1413.
    >> Share

  21. MORIZANE S, Miki J, Shimbo M, Kanno T, et al
    Japanese expert consensus on the standardization of robot-assisted pelvic lymph node dissection in urological surgery: Extent of pelvic lymph node and surgical technique.
    Int J Urol. 2024;31:1300-1310.
    >> Share


    J Cell Biochem


  22. RETRACTION: Upregulation of LncRNA SnoRNA Host Gene 6 Regulates NUAK Family SnF1-like Kinase-1 Expression by Competitively Binding MicroRNA-125b and Interacting with Snail1/2 in Bladder Cancer.
    J Cell Biochem. 2024 Dec 1:e30676. doi: 10.1002/jcb.30676.
    >> Share


    J Clin Invest

  23. SADHUKHAN P, Feng M, Illingworth EJ, Sloma I, et al
    YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/ STAT3 pathway and CXCL deregulation.
    J Clin Invest. 2024 Nov 21:e171164. doi: 10.1172/JCI171164.
    >> Share


    JCO Precis Oncol

  24. CRUPI E, Costa de Padua T, Marandino L, Fallara G, et al
    Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.
    JCO Precis Oncol. 2024;8:e2400470.
    >> Share


    Minerva Urol Nephrol

  25. FERRO M, Tataru OS, Fallara G, Fiori C, et al
    Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guerin response among bladder cancer patients: a novel machine-learning approach.
    Minerva Urol Nephrol. 2024 Dec 3. doi: 10.23736/S2724-6051.24.05876.
    >> Share


    Nan Fang Yi Ke Da Xue Xue Bao

  26. LI L, Guo Y, Wang C, Chang R, et al
    [High expression of miR-204-5p promotes malignant behaviors of bladder cancer cells by negatively regulating RAB22A].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:2235-2242.
    >> Share


    Nat Biomed Eng


  27. A two-phase point-of-care diagnostic device for bladder cancer.
    Nat Biomed Eng. 2024 Dec 2. doi: 10.1038/s41551-024-01301.
    >> Share


    Nat Commun

  28. TUCCI FA, Pennisi R, Rigiracciolo DC, Filippone MG, et al
    Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis.
    Nat Commun. 2024;15:10378.
    >> Share


    Nat Prod Res

  29. SILVEIRA BM, Amparo TR, Seibert JB, Almeida TC, et al
    Hydromethanolic fraction from Abatia americana (Salicaceae) inhibits T24 bladder cancer cell line and the bacterium Listeria monocytogenes with high selectivity.
    Nat Prod Res. 2024 Dec 5:1-5. doi: 10.1080/14786419.2024.2435536.
    >> Share


    PeerJ

  30. ZHANG Z, Liu F, Yu Y, Xie F, et al
    Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis.
    PeerJ. 2024;12:e18530.
    >> Share


    Sci Rep

  31. HU HY, Hu SY, Yang M, Hu Y, et al
    Hu similarity coefficient: a clinically oriented metric to evaluate contour accuracy in radiation therapy.
    Sci Rep. 2024;14:30215.
    >> Share


    Stem Cells Int

  32. YANG E, Ji L, Zhang X, Jing S, et al
    Identification of a Novel Mesenchymal Stem Cell-Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer.
    Stem Cells Int. 2024;2024:6064671.
    >> Share


    Toxicol In Vitro

  33. TERZI E, Oz-Bedir BE, Ercan E, Ozdemir-Sanci T, et al
    beta-Arbutin and cisplatin: A combined approach to modulating apoptosis, cell viability, and migration in bladder cancer cells.
    Toxicol In Vitro. 2024 Dec 3:105985. doi: 10.1016/j.tiv.2024.105985.
    >> Share


    Urol Int

  34. CHEN H, Wu M, Chen M
    Evaluation of the Management of Urachal Carcinoma: A Single-Center Experience over 13 Years.
    Urol Int. 2024;108:508-516.
    >> Share


    Urology

  35. ECKE TH, Meisl CJ, Schlomm T, Rabien A, et al
    Performance of urinary markers in patients with suspicious cystoscopy during follow-up of recurrent non-muscle invasive bladder cancer: BTA stat(R), NMP22(R) BladderChek(R), UBC(R) Rapid Test, CancerCheck(R) UBC(R) rapid VISUAL, and uromonitor(R) in c
    Urology. 2024 Dec 1:S0090-4295(24)01113-0. doi: 10.1016/j.urology.2024.
    >> Share


    World J Urol

  36. CAMPBELL T, Hunt TC, Li A, Cheng Z, et al
    Analysis of Genitourinary Rhabdomyosarcoma in Phase 3 clinical trials.
    World J Urol. 2024;43:6.
    >> Share

  37. GABRIEL PE, Ganesan V, Krishnan J, Autorino R, et al
    Pure open versus robotic radical cystectomy with intracorporeal urinary diversion: a propensity matched analysis.
    World J Urol. 2024;43:13.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016